news

support for entrepreneurs within the company program, "Asuniwa project" won a Special Jury Prize at the "Bizcon AWARDS 2026."

Announcement Regarding the Acquisition of Shares (Making it a Subsidiary) of Magic Cod doo, a Cosmetics Distributor in the Republic of Serbia

Rohto Pharmaceutical and Osaka Prefecture are jointly organizing Feminine Care seminar for mothers and daughters titled "Understanding Women's Bodies and Self-Care Correctly as a Mother and Daughter."

Rohto Pharmaceutical and Eu Yan Sang Skincare have collaborated for the first time. New products will be released from the medical institution-exclusive brand "Dermacept RX Stem Advance®".

Rohto Group discovers new potential in its proprietary material for tooth development and salivary gland activation.

Bringing the joy of sight to the world, across borders! Our "Eye Care Support Activity," now in its 10th year with 10 business partners, has raised a total of approximately 19 million yen in support.

Rohto Pharmaceutical begins demonstration of transporting skincare-related products and other items using T2 autonomous trucks.

Confirmation of the involvement of Cordyceps sinensis extract in maintaining the hair follicle growth phase.

Cordyceps extract improves the function of epidermal cells with reduced metabolism.

StemCM, a peptide-derived secretome born from Regenerative medicine research, suppresses skin damage caused by heat stress in a multifaceted way.

Introducing "Gyutto Corset Hair Milk," a texture-shaping hair milk that focuses on the "return of frizz" during the day.

Iga City, Mie Prefecture x Rohto Pharmaceutical Co., Ltd. conduct a pilot educational program to prevent myopia in children.

Focusing on CMC damage inside the hair caused by sunlight, potassium hyaluronate was confirmed to have an effect in suppressing "frizz recurrence."

Rohto has discovered that its unique milk peptide ingredient acts not only on bones and blood, but also on growing muscles!

Rohto Pharmaceutical's "Mirumirunobiru" project has launched.

Rohto Pharmaceutical joins "ASAGI Labs Longevity Consortium"

Based on cell research, we will accelerate the social implementation of "longevity" science.

ROHTO Zi ® Slime eye drops are now King Slime eye drops! The third installment of this popular collaboration eye drop series is available in limited quantities!

Automated HPLC analysis sample preparation system for quality control is being developed for practical use.

Certified as an "Excellent Food Education Practice Corporation 2026" by the Ministry of Agriculture, Forestry and Fisheries.

Regarding the issue of the old DRX brand website URL being redirected to a fraudulent site.

Initiatives to Ensure Safety in Cell Therapy

Notice of changes to packaging specifications due to environmental considerations

Publication of "Rohto Health White Paper 2025"

Please purchase from authorized Obagi retailers.

Initiatives to Ensure Safety in Cell Therapy

Setting new health and productivity management indicators for 2030

Report and Apology Regarding the Consumer Affairs Agency's Corrective Order

Revision of the "Multi-Stakeholder Policy"

Report and Apology Regarding the Consumer Affairs Agency's Corrective Order

Rohto Group formulates "Basic Policy on Customer Harassment"

Please be careful of suspicious investment solicitations related to our company.

Beware of counterfeit "Lush Rich" products

Please be aware of suspicious e-mails purporting to be from our company's employees and directors

Beware of counterfeit Obagi C25 Serum NEO products

Information about the pigments used in our sunscreen products

Notice of revision of precautions for use of eye drops (over-the-counter drugs) containing sodium sulfamethoxazole

Please be aware of suspicious e-mails purporting to be from our company's employees and directors

Regarding some reports about our company

On the occasion of our 125th anniversary, our corporate slogan and logo design have been renewed.

The recipients of the 17th Rohto Women's Health Science Research Award have been decided.

The winners of the 31st ROHTO AWARD research grants have been decided.

Recipients of the "Japanese Dermatological Association Dermatological Research Fund (Endowment by Rohto Pharmaceutical)" have been decided

We are pleased to announce the 19th recipient of Rohto Prize, a research fund specializing in Japanese Association of Geriatric Dermatology Research Fund skin.

Announcement of the public call for applications for the "Japanese Dermatological Association Dermatological Research Fund (Endowment by Rohto Pharmaceutical)"

The 16th recipients of the Rohto Women's Health Science Research Award have been announced

The recipients of the 30th ROHTO AWARD research grant have been decided.

Recipients of the "Japanese Dermatological Association Dermatological Research Fund (Endowment by Rohto Pharmaceutical)" have been decided

Announcement of the public call for applications for the "Japanese Dermatological Association Dermatological Research Fund (Endowment by Rohto Pharmaceutical)"

We are pleased to announce the 18th recipient of Rohto Prize, a research fund specializing in Japanese Association of Geriatric Dermatology Research Fund skin.

The 4th Rohto Regenerative medicine Forum was held

The 15th recipients of the Rohto Women's Health Science Research Award have been announced

The recipients of the 29th ROHTO AWARD research grant have been decided.

Recipients of the "Japanese Dermatological Association Dermatological Research Fund (Endowment by Rohto Pharmaceutical)" have been decided

Announcement of the public call for applications for the "Japanese Dermatological Association Dermatological Research Fund (Endowment by Rohto Pharmaceutical)"

We are pleased to announce the 17th recipient of Rohto Prize, a research fund specializing in Japanese Association of Geriatric Dermatology Research Fund skin.

The 3rd Rohto Regenerative medicine Forum was held

The 14th recipients of the Rohto Women's Health Science Research Award have been announced

The recipients of the 28th ROHTO AWARD research grant have been decided.

Recipients of the "Japanese Dermatological Association Dermatological Research Fund (Endowment by Rohto Pharmaceutical)" have been decided